Loading clinical trials...
Loading clinical trials...
The purpose of this study is to document how often and how severe are the breathing difficulties that patients suffer, while recovering on a general ward following a serious operation
This is a prospective, 2-center, 2-phase pilot study of post-surgical adult patients on the hospital ward at high risk of developing respiratory and cardiovascular events. Phase I, 70 patients will be 1:1 randomly allocated to Capnostream 20p monitoring system or to PM1000N-RR pulse oximeter monitoring system and the alarms of both devices will be silenced and the screen information blinded, to establish a baseline for the incidence of respiratory events. Phase II, 140 patients will be 1:1 randomly allocated to Capnostream 20p or to PM1000N-RR monitoring but the screen information will be visible at the bedside and through the Vital Sync™ remote patient monitoring system.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Universitätsklinikum Bonn
Bonn, Germany
Universitätsklinikum Gießen und Marburg
Marburg, Germany
Start Date
May 9, 2019
Primary Completion Date
December 14, 2019
Completion Date
December 14, 2019
Last Updated
March 8, 2021
6
ACTUAL participants
Capnostream 20 monitoring
BEHAVIORAL
PM1000N-RR monitoring
DEVICE
Lead Sponsor
Medtronic - MITG
NCT06719258
NCT06412081
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06443515